| 000 | 01868 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517082437.0 | ||
| 264 | 0 | _c20161229 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1096-0023 | ||
| 024 | 7 |
_a10.1016/j.cyto.2016.02.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPtaszynska-Kopczynska, Katarzyna | |
| 245 | 0 | 0 |
_aAlterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure. _h[electronic resource] |
| 260 |
_bCytokine _cApr 2016 |
||
| 300 |
_a7-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntigens, CD _xblood |
| 650 | 0 | 4 |
_aAntigens, Differentiation, Myelomonocytic _xblood |
| 650 | 0 | 4 |
_aAspirin _xanalogs & derivatives |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCytokine TWEAK |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 |
_aInflammation _xetiology |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 |
_aLysine _xanalogs & derivatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xblood |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTumor Necrosis Factors _xblood |
| 650 | 0 | 4 | _aCD163 Antigen |
| 700 | 1 | _aMarcinkiewicz-Siemion, Marta | |
| 700 | 1 | _aLisowska, Anna | |
| 700 | 1 | _aWaszkiewicz, Ewa | |
| 700 | 1 | _aWitkowski, Marcin | |
| 700 | 1 | _aJasiewicz, Malgorzata | |
| 700 | 1 | _aMiklasz, Paula | |
| 700 | 1 | _aJakim, Piotr | |
| 700 | 1 | _aGalar, Bogdan | |
| 700 | 1 | _aMusial, Wlodzimierz Jerzy | |
| 700 | 1 | _aKaminski, Karol Adam | |
| 773 | 0 |
_tCytokine _gvol. 80 _gp. 7-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cyto.2016.02.005 _zAvailable from publisher's website |
| 999 |
_c25770719 _d25770719 |
||